Literature DB >> 25064371

Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Yushi Chikasawa1, Keiko Shinozawa, Kagehiro Amano, Kyoichi Ogata, Takeshi Hagiwara, Takashi Suzuki, Hiroshi Inaba, Katsuyuki Fukutake.   

Abstract

We investigated a mildly hemorrhagic patient with factor X (FX) deficiency to identify the nature of his defect by comprehensive analyses. A 42-year-old Japanese man was admitted to our hospital for uncontrolled gingival hemorrhage. His FX activity based on prothrombin time (PT) and activated partial thromboplastin time (aPTT) and FX antigen were <1, 6.5 and 11 %, respectively. A homozygous M402T missense mutation (c.1205 t>c; p.Met402Thr) was identified in the FX gene (F10) from both the patient and his brother. The mutation was not detected in the F10 of 82 unrelated normal Japanese individuals. We studied the functional consequences of this mutation by expressing mutant FX-M402T protein in HEK293 cells. This analysis revealed that the antigen of the FX-M402T mutants was approximately 26 % that of the wild-type FX in conditioned media. The FX-specific activity of FX-M402T mutants measured by a one-stage clotting assay based upon PT and aPTT, and a chromogenic assay using Russell's viper venom in the concentrated media was 7.7, 31.7, and 41.2 % of wild type, respectively. The results suggest that the mutation FX-M402T may cause a secretion defect and a molecular abnormality in FX.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25064371     DOI: 10.1007/s12185-014-1643-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  36 in total

1.  Molecular analysis of the genotype-phenotype relationship in factor X deficiency.

Authors:  D S Millar; L Elliston; P Deex; M Krawczak; A I Wacey; J Reynaud; H K Nieuwenhuis; P Bolton-Maggs; P M Mannucci; J C Reverter; P Cachia; K J Pasi; D M Layton; D N Cooper
Journal:  Hum Genet       Date:  2000-02       Impact factor: 4.132

2.  The gene for clotting factor 10 is mapped to 13q32----qter.

Authors:  N J Royle; M R Fung; R T MacGillivray; J L Hamerton
Journal:  Cytogenet Cell Genet       Date:  1986

3.  Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency.

Authors:  M Giansily-Blaizot; P Aguilar-Martinez; C Biron-Andreani; P Jeanjean; H Igual; J F Schved
Journal:  Eur J Hum Genet       Date:  2001-02       Impact factor: 4.246

Review 4.  Rare coagulation deficiencies.

Authors:  F Peyvandi; S Duga; S Akhavan; P M Mannucci
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

5.  Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency.

Authors:  Flora Peyvandi; Marzia Menegatti; Elena Santagostino; Sepideh Akhavan; James Uprichard; David J Perry; Stephen J Perkins; Pier M Mannucci
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

6.  Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.

Authors:  A K Sabharwal; K Padmanabhan; A Tulinsky; A Mathur; J Gorka; S P Bajaj
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

7.  Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys).

Authors:  I M Nöbauer-Huhmann; W Höller; B Krinninger; P L Turecek; G Richter; I Scharrer; E Forberg; H H Watzke
Journal:  Blood Coagul Fibrinolysis       Date:  1998-03       Impact factor: 1.276

8.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

9.  Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

Authors:  F H Herrmann; K Wulff; G Auerswald; S Schulman; J Astermark; A Batorova; W Kreuz; H Pollmann; A Ruiz-Saez; N De Bosch; L Salazar-Sanchez
Journal:  Haemophilia       Date:  2008-10-30       Impact factor: 4.287

10.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.